Member Info for _Mr_Big

You beat me to it Joey.

Dunno oily, if holding SNG means I have to watch that tw.t every night, I'm not sure the gains are worth it... Actually, they are - huge upside.

Ah well, made a wee top-up in case we never see these levels again.

Oil - yes, I think a few TR1s will follow. Performance exceptionally strong after big Monday.
I was starting to get worried we weren't getting any.

Oil - have you spotted a Code 1?

Thanks.

SGD - at the moment I believe that no peer review is required for publications - they have all been suspended to boost research to fight the virus. So anything can get published with a caveat "Not peer reviewed".
Back to my point - how many £ does a peer review add to our SP? Almost irrelevant as it will be pharmas with offers based on their own research.
Sure, would be good to get some big headed guys to say "this stuff works". But our stuff either works or it does not. And we might get bought out before anyone knows for sure.
Unless I am missing something here.

Thank you.

Phil - Just joking, obviously.

"Peer review failure" would need to be defined.
From Mrs B experience, peer reviews are just about professors all over the world coming up with bitter excuses because it's not them who's done the research... It's very far from "great minds collaborating on a research project" scenario.

Question is: do we even need it, when all we need for commercial success is interest from a pharma (with their own brainy guys on the payroll) and reg approval. The latter might not even be immediately required under right to try, which will boost our results sample size.

Is my maths a bit off? It's been a while since I learned about probability 8)

Cosh... LSE (and AIM for that matter) might not be the best place for a newbie PI... As you might have noticed, I don't believe in taking LSE very seriously.
There are many ways to make money on the stock market, but there are even more ways to lose it, so be careful.
I'd say, if you have a good macroeconomic background, then you can play on trends. If you have industry-specific knowledge, use that edge to focus on the industry and pick the winners. If you have trading skills, then play the volumes, but most folk lose money on it.
Don't chase rainbows and don't give in to the herd panic when something's going up or down.

And if it's messing with your head, just sell - your health is not worth it.

Mani - I think you mis-read Hold4.
All pharmas have bubbled in Mar-May. They then slowed down, but seem to be picking up again (could be just SNG money from Big Monday being spread across the sector). This is not SNg-specific.

I think there is big macro benefit for all pharmas from covid though - all research is accelerated, so in the long term we might have shaved off years of research and testing.

Don't know about you, but I am banking on oil for the medium term.

Gold is so yesterday.

Yes, typical AIM punter wants returns on the same day. There are some "investors" with long-term outlook that might hold a stock for a week or two.

They'll be back. Another covid bubble coming our way.

You're right woodie.
We're either getting a deal/buy out or we ain't.
So there's only a 50% chance of us cashing in.

Kerchingairgenned was the term coined yesterday I believe.

See, I told you there was an RNS coming.

You heard it from Mr B first.

I've got the buy button lubed up - just waiting for the dip.

Yes, I am very disappointed with the coverage and the UK response.